retatrutide results before and after just delivered the first top-line Phase 3 for a triple agonist in obesity β the findings from TRIUMPH-4 are strikingπ Retatrutide Before and After: Doctor
Description
Assessing Provider Alignment With Personalized Treatment Approaches Evidence-based providers recognize that GLP-1 response varies widely among individuals due to genetic, metabolic, and lifestyle factors

While alcohol is currently the primary focus, interest is expanding to other substance use disorders, including nicotine dependence and opioid use

This population is more likely to benefit from the potent metabolic and anti-inflammatory effects of the drug

Wegovy (pill): Taken once daily, starting with 1.5 mg and gradually increased every 30 days, or as needed but not earlier than every 30 days, up to 25 mg

This is more sophisticated than what some compounders offer

Yes, there are non-injectable GLP-1 medications available, but theyre mostly used to treat type 2 diabetes rather than for weight loss
